Celgene Corp. /de/, 10% Owner at CRISPR Therapeutics AG (CRSP), sold 87,991 shares at $19.10 ($1.7M) on 2017-12-01, disclosed to the SEC on 2017-12-07.
Open-market sale of $1.7M CRSP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| XLRN | BUY | 2019-01-22 | $30.4M | — | Filing → |
| AGIO | BUY | 2018-01-23 | $57.0M | — | Filing → |
| CRSP | SELL | 2017-12-07 | $19.6M | — | Filing → |